Nutriband Inc NTRB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
5.09quote price arrow up+1.38 (+37.23%)
Volume
176,323
52 week range
1.53 - 5.93
Loading...
  • Open4.10
  • Day High5.09
  • Day Low3.81
  • Prev Close3.71
  • 52 Week High5.93
  • 52 Week High Date03/28/24
  • 52 Week Low1.53
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap55.837M
  • Shares Out10.97M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change117.67

KEY STATS

  • Open4.10
  • Day High5.09
  • Day Low3.81
  • Prev Close3.71
  • 52 Week High5.93
  • 52 Week High Date03/28/24
  • 52 Week Low1.53
  • 52 Week Low Date10/27/23
  • Market Cap55.837M
  • Shares Out10.97M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change117.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.69
  • P/E (TTM)-7.42
  • Fwd P/E (NTM)-118.37
  • EBITDA (TTM)-4.584M
  • ROE (TTM)-73.08%
  • Revenue (TTM)2.085M
  • Gross Margin (TTM)41.34%
  • Net Margin (TTM)-263.05%
  • Debt To Equity (MRQ)3.22%

EVENTS

  • Earnings Date06/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nutriband Inc

 

Content From Our Affiliates

Profile

MORE
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. The Company's development pipeline includes AVERSA Buprenorphine and AVERSA Methylphenidate. The Company is also developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically...
Serguei Melnik
Chairman of the Board, President, Secretary
Gareth Sheridan
Chief Executive Officer, Founder, Director
Alan Smith Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Gerald Goodman
Chief Financial Officer, Chief Accounting Officer
Patrick Ryan
Chief Technical Officer
Address
121 S Orange Ave Ste 1500
Orlando, FL
32801-3241
United States

Top Peers

SYMBOLLASTCHG%CHG
SABS
SAB Biotherapeutics Inc
3.93-0.11-2.84%
OCX
OncoCyte Corp
2.89-0.01-0.34%
OMIC
Singular Genomics Systems Inc
0.38-0.0496-11.5456%
DYAI
Dyadic International Inc
1.57+0.08+5.37%
HCWB
HCW Biologics Inc
1.16+0.01+0.87%